Anadys Pharmaceuticals Stock Price, News & Analysis (NASDAQ:ANDS)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Anadys Pharmaceuticals (NASDAQ:ANDS)

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company engaged in developing medicines for the treatment of hepatitis C. The Company is focusing on the development of ANA598, a direct-acting antiviral (DAA) for the treatment of hepatitis C. It also focuses to resume the clinical development of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway for the treatment of hepatitis C. In January 2011, the Company initiated a Phase IIb clinical study of ANA598 in combination with SOC for the treatment of hepatitis C. In the Phase IIb study, approximately 200 chronically infected genotype 1 hepatitis C patients are to receive ANA598 200 mg bid in combination with standard of care (SOC), with a loading dose of 800 mg ANA598 bid on day one. In addition, approximately 66 chronically infected genotype 1 hepatitis C patients are to receive placebo added to SOC.

Receive ANDS News and Ratings via Email

Sign-up to receive the latest news and ratings for ANDS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Anadys Pharmaceuticals (NASDAQ:ANDS) Frequently Asked Questions

What is Anadys Pharmaceuticals' stock symbol?

Anadys Pharmaceuticals trades on the NASDAQ under the ticker symbol "ANDS."

Who are some of Anadys Pharmaceuticals' key competitors?

How do I buy Anadys Pharmaceuticals stock?

Shares of Anadys Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Anadys Pharmaceuticals?

Anadys Pharmaceuticals' mailing address is Suite 200, 5871 Oberlin Drive, SAN DIEGO, CA 92121, United States. The biopharmaceutical company can be reached via phone at +1-858-5303600.

MarketBeat Community Rating for Anadys Pharmaceuticals (ANDS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  95
MarketBeat's community ratings are surveys of what our community members think about Anadys Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Anadys Pharmaceuticals (NASDAQ:ANDS) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Anadys Pharmaceuticals (NASDAQ:ANDS) Earnings History and Estimates Chart

Earnings by Quarter for Anadys Pharmaceuticals (NASDAQ:ANDS)

Anadys Pharmaceuticals (NASDAQ ANDS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2011($0.14)($0.15)ViewN/AView Earnings Details
8/8/2011($0.12)($0.14)ViewN/AView Earnings Details
5/5/2011($0.10)($0.10)ViewN/AView Earnings Details
3/3/2011($0.09)($0.04)ViewN/AView Earnings Details
11/8/2010Q3 2010($0.10)($0.11)ViewN/AView Earnings Details
7/29/2010Q2 2010($0.14)($0.08)ViewN/AView Earnings Details
4/27/2010Q1 2010($0.17)($0.17)ViewN/AView Earnings Details
2/24/2010Q4 2009($0.17)($0.15)ViewN/AView Earnings Details
10/29/2009Q3 2009($0.20)($0.21)ViewN/AView Earnings Details
7/30/2009Q2 2009($0.27)($0.21)ViewN/AView Earnings Details
4/23/2009Q1 2009($0.30)($0.30)ViewN/AView Earnings Details
2/26/2009Q4 2008($0.33)($0.30)ViewN/AView Earnings Details
10/23/2008Q3 2008($0.26)($0.32)ViewN/AView Earnings Details
7/30/2008Q2 2008($0.28)($0.25)ViewN/AView Earnings Details
4/30/2008Q1 2008($0.26)($0.26)ViewN/AView Earnings Details
2/20/2008Q4 2007($0.28)($0.27)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Anadys Pharmaceuticals (NASDAQ:ANDS) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Anadys Pharmaceuticals (NASDAQ:ANDS)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Anadys Pharmaceuticals (NASDAQ ANDS)

No insider trades for this company have been tracked by


Anadys Pharmaceuticals (NASDAQ ANDS) News Headlines

No headlines for this company have been tracked by

SEC Filings

Anadys Pharmaceuticals (NASDAQ:ANDS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Anadys Pharmaceuticals (NASDAQ:ANDS) Income Statement, Balance Sheet and Cash Flow Statement


Anadys Pharmaceuticals (NASDAQ ANDS) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.